'Unprecedented' demand for Eli Lilly's Zepbound sparks US supply constraints
'Unprecedented' demand for Eli Lilly's Zepbound sparks US supply constraints zbecker Fri, 03/29/2024 - 13:15
'Unprecedented' demand for Eli Lilly's Zepbound sparks US supply constraints zbecker Fri, 03/29/2024 - 13:15
Teva, following Hikma complaint, alleges Amarin 'locked up' Vascepa ingredient to block generics fkansteiner Fri, 03/29/2024 - 11:47
The unrecognized threat of PAD aellison Fri, 03/29/2024 - 11:42
J&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti kdunleavy Fri, 03/29/2024 - 11:04
After Amgen's stumble, BMS touts KRAS confirmatory trial win for newly bought Krazati aliu Fri, 03/29/2024 - 10:18
Bristol Myers Squibb's versatile Zeposia doesn't make the grade in Crohn's disease trial kdunleavy Fri, 03/29/2024 - 07:43